| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 20.968 | 24.525 | 36.167 | 33.694 | 27.001 | 51.294 | 72.700 |
| Total Income - EUR | - | - | 0 | 20.968 | 24.525 | 36.167 | 35.514 | 27.001 | 53.383 | 72.702 |
| Total Expenses - EUR | - | - | 278 | 15.704 | 28.858 | 34.234 | 34.587 | 39.588 | 50.558 | 56.849 |
| Gross Profit/Loss - EUR | - | - | -278 | 5.264 | -4.333 | 1.933 | 927 | -12.587 | 2.825 | 15.852 |
| Net Profit/Loss - EUR | - | - | -278 | 5.054 | -4.579 | 1.583 | 615 | -12.857 | 2.292 | 13.857 |
| Employees | - | - | 1 | 2 | 4 | 5 | 5 | 6 | 6 | 6 |
Check the financial reports for the company - Teo & Luca Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 54 | 7.548 | 5.903 | 10.856 | 9.614 | 5.570 | 15.680 | 13.532 |
| Inventories | - | - | 0 | 2.095 | 1.810 | 2.495 | 3.969 | 4.176 | 1.736 | 1.726 |
| Receivables | - | - | 0 | 2.975 | 2.421 | 5.704 | 5.524 | 1.143 | 4.335 | 2.994 |
| Cash | - | - | 54 | 2.478 | 1.672 | 2.657 | 121 | 250 | 9.609 | 8.811 |
| Shareholders Funds | - | - | -234 | 4.825 | 152 | 1.733 | 2.310 | -10.540 | -8.217 | 5.686 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 365 | 2.724 | 5.751 | 9.123 | 7.304 | 16.110 | 23.897 | 7.845 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Teo & Luca Med Srl